OMDA

Omada Health, Inc. (OMDA)

Market Closed
12 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
NASDAQ (NGS) NASDAQ (NGS) Primary
$
15. 08
-0.33
-2.14%
$
- Market Cap
- P/E Ratio
- Div Yield
690,672 Volume
- Eps
$ 15.41
Previous Close
Day Range
14.94 15.45
Year Range
14.14 28.4
Want to track OMDA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Earnings results expected in 53 days

Summary

OMDA closed yesterday lower at $15.08, a decrease of 2.14% from Thursday's close, completing a monthly decrease of -34.55% or $7.96. Over the past 12 months, OMDA stock lost -34.43%.
OMDA is not paying dividends to its shareholders.
The last earnings report, released on Nov 06, 2025, exceeded the consensus estimates by 0.1%. On average, the company has surpassed earnings expectations by 0.09%, based on the last three reports. The next scheduled earnings report is due on Feb 05, 2026.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

OMDA Chart

No Data
Omada Health: Business Is Scaling Very Healthily

Omada Health: Business Is Scaling Very Healthily

Omada Health remains a 'Buy' as Q3 results validated strong growth, with revenue up 50% y/y to $68 million and membership reaching 831,000. OMDA's new GLP-1 prescribing capability deepens client integration, enhances ROI, and strengthens competitive positioning in a complex medication landscape. Multi-condition adoption accelerated, with ~75% of new customers using multiple programs, driving operating leverage and reducing client churn risk for OMDA.

Seekingalpha | 1 week ago
Omada Health, Inc. (OMDA) Q3 2025 Earnings Call Transcript

Omada Health, Inc. (OMDA) Q3 2025 Earnings Call Transcript

Omada Health, Inc. ( OMDA ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Allan Kells - Vice President of Investor Relations Sean Duffy - Co-Founder, CEO & Director Wei-Li Shao - President Steven Cook - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Chase & Co, Research Division Craig Hettenbach - Morgan Stanley, Research Division Richard Close - Canaccord Genuity Corp., Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Saket Kalia - Barclays Bank PLC, Research Division Ryan MacDonald - Needham & Company, LLC, Research Division David Roman - Goldman Sachs Group, Inc., Research Division Gene Mannheimer Presentation Operator Good day, and thank you for standing by. Welcome to the Omada Health Third Quarter 2025 Earnings Conference Call.

Seekingalpha | 1 month ago
Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics

Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics

The headline numbers for Omada Health, Inc. (OMDA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 1 month ago

Omada Health, Inc. (OMDA) FAQ

What is the stock price today?

The current price is $15.08.

On which exchange is it traded?

Omada Health, Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is OMDA.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 05, 2026.

Has Omada Health, Inc. ever had a stock split?

No, there has never been a stock split.
Affiliate Program About Terms Privacy Help Contact Us
2025 © Marketlog. All Rights Reserved.
Play store app banner Play store app banner dark App store app banner App store app banner dark